env4q21earningssupplemen

2 Safe Harbor Disclosure This presentation contains forward-looking statements. These forward-looking statements include, in particular, statements about our plans, strategies and prospects. These statements are based on our current expectations and projections about future events. The words “may,” “will,” “should,” “could,” “expect,” “scheduled,” “plan,” “seek,” “intend,” “anticipate,” “believe,” “estimate,” “aim,” “potential” or “continue” or the negative of those terms or other similar expressions are intended to identify forward-looking statements and information. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates. These forward-looking statements are based on assumptions and estimates by our management that, although we believe to be reasonable, are inherently uncertain and subject to risks and uncertainties that could cause actual results to differ from those anticipated or predicted by our forward-looking statements. These risks and uncertainties include those described in our filings with the SEC. In light of these risks and uncertainties, the matters referred to in the forward-looking statements contained in this presentation may not in fact occur. We undertake no obligation to update or revise any forward-looking statement after the date of this presentation as a result of new information, future events or otherwise, except as required by law. We qualify all of our forward-looking statements by these cautionary statements.

3 Non-GAAP Disclosure Statement This presentation contains the non-GAAP financial measures, “adjusted revenues”, “adjusted EBITDA”, “adjusted net income” and “adjusted net income per diluted share”. • “Adjusted revenues” excludes the effect of purchase accounting on the fair value of acquired deferred revenue. Under GAAP, we record at fair value the acquired deferred revenue for contracts in effect at the time the entities were acquired. Consequently, revenue related to acquired entities for periods subsequent to the acquisition does not reflect the full amount of revenue that would have been recorded by these entities had they remained stand-alone entities. Adjusted revenues has limitations as a financial measure, should be considered as supplemental in nature and is not meant as a substitute for revenue prepared in accordance with GAAP. • “Adjusted EBITDA” represents net income (loss) before deferred revenue fair value adjustment, interest income, interest expense, accretion on contingent consideration and purchase liability, income tax provision (benefit), depreciation and amortization, non-cash compensation expense, restructuring charges and transaction costs, severance, fair market value adjustment on contingent consideration liability, fair market value adjustment on investment in private company, litigation and regulatory related expenses, foreign currency, gain on settlement of liability, gain on insurance reimbursement, non-income tax expense adjustment, gain on acquisition of equity method investment, gain on sale of interest in private company, income or loss allocations from equity method investments and (income) loss attributable to non-controlling interest. • “Adjusted net income” represents net income before deferred revenue fair value adjustment, accretion on contingent consideration and purchase liability, non-cash interest expense, cash interest on our convertible notes (subsequent to the adoption of ASU 2020-06 on January 1, 2021), non-cash compensation expense, restructuring charges and transaction costs, severance, amortization of acquired intangibles and fair value adjustment to property and equipment, net, fair market value adjustment on contingent consideration liability, fair market value adjustment to investment in private company, litigation and regulatory related expenses, foreign currency, gain on settlement of liability, gain on insurance reimbursement, non-income tax expense adjustment, gain on acquisition of equity method investment, gain on sale of interest in private company, gain on insurance reimbursement, fair market value adjustment to investment in private company, income or loss allocations from equity method investments and (income) loss attributable to non-controlling interest. Reconciling items are presented gross of tax, and a normalized tax rate is applied to the total of all reconciling items to arrive at adjusted net income. The normalized tax rate is based solely on the estimated blended statutory income tax rates in the jurisdictions in which we operate. We monitor the normalized tax rate based on events or trends that could materially impact the rate, including tax legislation changes and changes in the geographic mix of our operations. • “Adjusted net income per diluted share” represents adjusted net income attributable to common stockholders divided by the diluted number of weighted-average shares outstanding. Beginning January 1, 2021, the dilutive effect of our Convertible Notes are calculated using the if-converted method in accordance with the adoption of ASU 2020- 06. As a result, 9.9 million potential shares to be issued in connection with our Convertible Notes are considered to be dilutive for purposes of the adjusted net income per diluted share calculation beginning January 1, 2021. These measures are not calculated in accordance with GAAP and may be calculated differently than similar non-GAAP measures for other companies. Quantitative reconciliations of our non-GAAP financial information to the most directly comparable GAAP information appear in the appendix to this presentation. Reconciliations are not provided for guidance on such measures as we are unable to predict the amounts to be adjusted, such as the GAAP tax provision. Our non-GAAP financial measures should not be viewed as a substitute for revenues, net income (loss) or net income (loss) per share determined in accordance with GAAP.

4 Key Messages for Today Progress on our strategy Reporting Q4 2021 results and introducing full year 2022 guidance Investments have strengthened our franchise and are driving growth

5 Envestnet – A Powerful Story a massive and powerful set of Data All networked to solve an expanding set of customer needs that powers the most modern, connected Technology that drives implementation from the biggest product marketplace of Solutions

6 Proven Record of Innovation and Growth Cloud-based TAMP Advisor-as- Portfolio- Manager UMA Tamarac RIA solution Advice-centric platform Data Aggregation Financial planning TAMP Integrated Wealth Platform Financial Wellness Ecosystem Fully mobile WM platform Credit Exchange Niche advisory/ small business Trust Services Exchange Insurance Exchange Advanced AI recommendations Client apps Developer tools

7 Market and Industry Leading Footprint +17,000 data sources +500 million linked consumer accounts ~32 million Users** +625 FinTech Companies ~108,000 advisors ~$5.7 trillion in assets +17.5 million investor accounts 18 of 20 of the largest U.S. Banks 47 of 50 of the largest wealth management and brokerage firms +500 of the largest Registered Investment Advisers *Metrics as of December 31, 2021 **Paid subscribers

8 The Three Pillars of the Envestnet strategy Capture more of the addressable market Modernize the digital engagement marketplace Open the platform to the ecosystem Leveraging our scale and $5.7T in platform assets for growth Investing in leading digital experiences that drive client engagement and action Drawing more advisors, consumers and developers onto the platform

9 Leading modern, digital engagements Deliver the BEST OF ENV with cloud-based APIs 11M+ daily insights Unified Proposal Tool Next Generation Client Experience Unified Portfolio Accounting Platform

10 Data recommendations and integrated technology drive increased productivity Recommendations dashboard enables to precisely direct support to: • Individual advisors • All clients in their book • ESG, tax, direct indexing opportunities • Insurance, credit, health opportunities Driving highly personalized solutions and sales productivity

11 Sustainable Investing Overlay Solutions Direct Indexing 4Q’2021 YoY Change Advisor Usage +24% +60% +52% Accounts +104% +49% +43% Assets +80% +57% +53% Expansion of Asset-Based Solutions1 Year-over-year change comparing December 31, 2021 vs December 31, 2020 Total >27K advisors +441K accounts ~$61B in assets 1 Please note that the same account could be counted in more than one bucket. Sustainable investment amounts reflect all types of sustainably-tagged assets on platform, not necessarily higher margin customized solutions.

12 Strong Fourth Quarter 2021 Results (in millions except per share amounts) 4Q21 Outlook Provided 11/8/21 4Q21 Results vs. Midpoint YoY Change (%)* Key Variance Drivers – Results vs. Outlook Adjusted revenues(1) $310-312 $319.7 +$8.7 +21% • Onboarded conversion early in the quarter which carried higher than expected cost of revenue Adjusted EBITDA(1) $54-55 $56.2 +$1.7 -13% • Progression of accelerated investments in the fourth quarter Adjusted net income per diluted share(1) $0.49 $0.50 -28% *YoY change represents 4Q21 results vs. 4Q20 results. (1) Non-GAAP financial measure. Please see appendix for reconciliations to the most directly comparable GAAP information.

13 Strong Full Year 2021 Results (in millions except for per share amounts) FY21 Initial Outlook Provided 2/25/21 FY21 Results vs. Midpoint YoY Change (%)* Key Variance Drivers – Results vs. Outlook Adjusted revenues(1) $1,105 - $1,120 $1,186.8 +$74 +19% • Driven mainly by strong net flows and favorable markets for the asset-based business Adjusted EBITDA(1) $225-$235 $261.7 +$31.7 +8% • Revenue outperformance and lower than expected operating expenses Adjusted net income per diluted share(1) $1.95-$2.08 $2.42 +$0.41 -6% *YoY change represents full year 2021 results vs. full year 2020 results ** Adjusted earnings per diluted share impact of adjusted revenue unfavorability, less favorability in asset-based cost of revenue (1) Non-GAAP financial measure. Please see appendix for reconciliations to the most directly comparable GAAP information.

14 2022 Full Year Outlook (in millions except for per share amounts) FY21 Actual Results Initial FY22 Outlook (2/24/22) FY22 Outlook vs. FY21 Primary Variance Drivers vs. Prior Year Adjusted revenues(1) $1,186.8 $1,360 - $1,385 +15-17% • Strong growth in asset-based revenue • Growth in subscription revenue Adjusted EBITDA(1) $261.7 $270 - $280 +3-7% • Partial restoration of normal operating expense plus annualized investments to drive long-term growth Adjusted EBITDA(1) Margin 22.1% 19.9% - 20.2% (186 bp–215 bp) Normalized effective tax rate 25.5% 25.5% n/a Diluted shares outstanding 65.3 66.5 +2% • Normal growth in diluted shares Adjusted net income per diluted share(1) $2.42 $2.30 – $2.40 (1-5%) • EBITDA growth offset by higher depreciation and amortization, also increasing share count (1) Non-GAAP financial measure. Please see appendix for reconciliations to the most directly comparable GAAP information. Please review slides 2 and 3 for additional disclosures.

15 Capital Position as of December 31, 2021 Cash and Cash Equivalents $429M Annual cash interest expense $11.1M(1) Debt Outstanding on Revolving Line of Credit ($500M) $0M Revolving Line of Credit SOFR + spread(2) Convertible Debt Maturing 2023 $345M Convertible Debt 2023 1.75% coupon Convertible Debt Maturing 2025 $517.5M Convertible Debt 2025 0.75% coupon Net Leverage Ratio 1.6x Strong Balance Sheet and Liquidity (1) Run rate as of 12/31/21. Includes convertible note coupon payments and undrawn fees on revolving line of credit. (2) Based on terms of new credit agreement entered into in February 2022. We estimate the spread to be 235 basis points based on our current leverage ratio.

Appendix

17 Outlook Table (a) The Company does not forecast net income and net income per diluted share due to the unpredictable nature of various items adjusted for non-GAAP disclosure purposes, including the periodic GAAP income tax provision. (1) Non-GAAP financial measure. Please see appendix for reconciliations to the most directly comparable GAAP information. The Company provided the following outlook for the first quarter and full year ending December 31, 2022. This outlook is based on the market value of assets on December 31, 2021. We caution that we cannot predict the market value of our assets on any future date. See slide 2 for more information. In Millions Except Adjusted EPS 1Q 2022 GAAP: Revenues: Asset-based $ 204.5 – 206.0 Subscription-based $ 114.0 – 115.0 Total recurring revenues $ 318.5 – 321.0 Professional services and other revenues $ 3.5 – 4.0 Total Revenues: $ 322.0 – 325.0 Asset-based cost of revenues $ 116.0 – 117.0 Total cost of revenues $ 124.5 – 125.5 Net income (a) Diluted shares outstanding 65.9 Net income per diluted share (a) Non-GAAP: Adjusted revenues(1): Asset-based $ 204.5 – 206.0 Subscription-based $ 114.0 – 115.0 Total recurring revenues $ 318.5 – 321.0 Professional services and other revenues $ 3.5 – 4.0 Total Revenues: $ 322.0 – 325.0 Adjusted EBITDA(1) $ 52.5 – 54.5 Adjusted net income per diluted share(1) $ 0.44 – 0.45 FY 2022 $ 1,360.0 – 1,385.0 (a) 66.5 (a) $ 1,360.0 – 1,385.0 $ 270.0 – 280.0 $ 2.30 – 2.40

18 Reconciliation of Non-GAAP Financial Measures Three Months Ended December 31, (in thousands) (unaudited) 2021 2020 Total revenues $ 319,621 $ 263,819 Deferred revenue fair value adjustment 57 85 Adjusted revenues $ 319,678 $ 263,904 Net income (loss) $ (5,310) $ 7,694 Add (deduct): Deferred revenue fair value adjustment 57 85 Interest income (258) (262) Interest expense 4,249 9,597 Income tax provision (benefit) (1,407) (5,240) Depreciation and amortization 29,515 28,584 Non-cash compensation expense 17,713 13,916 Restructuring charges and transaction costs 7,275 4,922 Severance 849 6,544 Accretion on contingent consideration and purchase liability 74 380 Fair market value adjustment on contingent consideration liability — (1,049) Fair market value adjustment to investment in private company — — Non-recurring litigation and regulatory related expenses 2,432 1,796 Foreign currency (117) 184 Non-recurring gains — (1,647) Gain on settlement of liability — — Gain on insurance reimbursement — — Non-income tax expense adjustment (245) (920) Loss allocation from equity method investments 1,540 1,119 Income attributable to non-controlling interest (150) (727) Adjusted EBITDA $ 56,217 $ 64,976 Year Ended December 31, 2021 2020 $ 1,186,517 $ 998,230 284 692 $ 1,186,801 $ 998,922 $ 12,694 $ (2,644) 284 692 (827) (1,112) 16,931 31,504 7,667 (5,401) 117,767 113,661 68,020 57,113 18,490 19,383 11,347 25,110 730 1,688 (1,067) (3,105) (758) — 7,591 7,825 (7) 116 — (5,877) (1,206) — (968) — (1,347) 421 7,093 5,399 (704) (1,830) $ 261,730 $ 242,943

19 Adjusted net income per share - diluted $ 0.50 $ 0.69 Reconciliation of Non-GAAP Financial Measures Three Months Ended December 31, (in thousands, except share and per share information) (unaudited) 2021 2020 Net income (loss) $ (5,310) $ 7,694 Income tax provision (benefit) (1,407) (5,240) Loss before income tax provision (benefit) (6,717) 2,454 Add (deduct): Deferred revenue fair value adjustment 57 85 Non-cash interest expense 1,450 6,798 Cash interest - Convertible Notes 2,480 — Non-cash compensation expense 17,713 13,916 Restructuring charges and transaction costs 7,275 4,922 Severance 849 6,544 Accretion on contingent consideration and purchase liability 74 380 Fair market value adjustment on contingent consideration liability — (1,049) Fair market value adjustment to investment in private company — — Amortization of acquired intangibles 17,217 17,545 Non-recurring litigation and regulatory related expenses 2,432 1,796 Foreign currency (117) 184 Non-recurring gains — (1,647) Gain on settlement of liability — — Gain on insurance reimbursement — — Non-income tax expense adjustment (245) (920) Loss allocation from equity method investments 1,540 1,119 Income attributable to non-controlling interest (150) (727) Adjusted net income before income tax effect 43,858 51,400 Income tax effect (11,184) (13,107) Adjusted net income $ 32,674 $ 38,293 Basic number of weighted-average shares outstanding 54,678,195 53,960,769 Effect of dilutive shares: Options to purchase common stock 201,300 290,366 . Unvested restricted stock units 665,222 622,702 . Convertible notes 9,898,549 769,593 . Warrants 93,947 89,989 . Diluted number of weighted-average shares outstanding 65,537,213 55,733,419 Year Ended December 31, 2021 2020 $ 12,694 $ (2,644) 7,667 (5,401) 20,361 (8,045) 284 692 5,745 17,480 9,919 — 68,020 57,113 18,490 19,383 11,347 25,110 730 1,688 (1,067) (3,105) (758) — 68,587 73,559 7,591 7,825 (7) 116 — (5,877) (1,206) — (968) — (1,347) 421 7,093 5,399 (704) (1,830) 212,110 189,929 (54,088) (48,432) $ 158,022 $ 141,497 54,470,975 53,589,232 206,022 416,593 633,384 592,033 9,898,549 414,398 73,715 58,459 65,282,645 55,070,715 $ 2.42 $ 2.57

20 Reconciliation of Non-GAAP Financial Measures 20 Note: Numbers may not sum due to rounding. Year Ended December 31, (in millions) (unaudited) 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 Net income (loss) 7.61 0.47 3.66 13.98 4.44 (55.57) (3.28) 4.01 (17.20) (2.64) 12.69 Accretion on contingent consideration and purchase liability - - - - 0.89 0.15 0.51 0.22 1.77 1.69 0.73 Contract settlement charges 1.18 - - - - - - - - - - Customer inducement costs 4.57 - - - - - - - - - - Deferred revenue fair value adjustment - 1.25 0.16 - 0.32 1.27 0.13 0.12 9.27 0.69 0.28 Depreciation and amortization 6.38 12.40 15.33 18.65 27.96 64.00 62.82 77.63 101.27 113.66 117.77 Fair market value adjustment to investment in private company - - - - - - - - - - (0.76) Fair market value adjustment on contingent consideration liability - - 0.50 (1.43) (4.15) 1.59 - - (8.13) (3.11) (1.07) Foreign currency - - - - - (0.72) 0.49 (0.59) (0.07) 0.12 (0.01) Impairment of customer inducement assets 0.17 - - - - - - - - - - Impairment of equity method investment - - - - - 0.73 - - - - - Imputed interest expense on contingent consideration - - 0.79 1.47 - - - - - - - Income tax provision (benefit) 2.98 2.60 2.05 8.53 4.55 15.08 1.59 (13.17) (30.89) (5.40) 7.67 Interest expense 0.79 - - 0.63 10.27 16.60 16.35 25.20 32.52 31.50 16.93 Interest income (0.08) (0.03) (0.02) (0.14) (0.34) (0.04) (0.20) (2.36) (3.35) (1.11) (0.83) Litigation related expense 0.13 0.27 0.01 0.02 0.07 5.59 1.03 - 2.88 7.83 7.59 Loss allocation from equity method investments - - - - - 1.42 1.47 1.15 2.36 5.40 7.09 (Income) loss attributable to non-controlling interest - - - 1.23 1.64 1.08 0.32 1.79 0.11 (1.83) (0.70) Non-cash compensation expense 3.06 4.04 8.92 11.42 15.16 33.28 31.33 40.25 60.44 57.11 68.02 Non-income tax expense adjustment - - - - - 6.23 0.35 (0.59) 0.37 0.42 (1.35) Non-recurring gains - - - - - - - - - (5.88) - Other (1.10) - - (1.83) 0.07 (1.38) - - - - - Re-audit related expenses - - 3.11 - - - - - - - - Restructuring charges and transaction costs 1.05 2.72 3.30 2.67 13.50 5.78 13.67 15.58 26.56 19.38 18.49 Severance 0.70 0.28 0.79 0.74 1.70 4.34 2.32 8.32 15.37 25.11 11.35 Gain on acquisition of equity method investment - - - - - - - - - (4.23) - Gain on settlement of liability - - - - - - - - - - (1.21) Gain on insurance reimbursement - - - - - - - - - - (0.97) Gain on sale of interest in private company - - - - - - - - - (1.65) - Adjusted EBITDA 27.44 23.99 38.59 55.94 76.07 99.44 128.89 157.55 193.29 242.94 261.73